OpenURL Connection Search

Select item for more details and to access through your institution.

Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein–Barr virus infection.
Published in:
Pathology International, 2001, v. 51, n. 10, p. 778, doi. 10.1046/j.1440-1827.2001.01276.x
By:
- Nagata, Hiroshi;
- Numata, Tsutomu;
- Konno, Akiyoshi;
- Mikata, Ittaku;
- Kurasawa, Kazuhiro;
- Hara, Satoru;
- Nishimura, Miki;
- Yamamoto, Kohtaro;
- Shimizu, Norio
Publication type:
Article
CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.
Published in:
Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1047, doi. 10.1093/jjco/hyx126
By:
- Yusuke Isshiki;
- Chikako Ohwada;
- Emiko Sakaida;
- Masahiro Onoda;
- Nobuyuki Aotsuka;
- Hiroaki Tanaka;
- Motoharu Fukazawa;
- Ryuko Cho;
- Takeaki Sugawara;
- Takeharu Kawaguchi;
- Satoru Hara;
- Akira Yokota
Publication type:
Article
Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
Published in:
British Journal of Haematology, 2013, v. 163, n. 2, p. 286, doi. 10.1111/bjh.12483
By:
- Tsukamoto, Shokichi;
- Nakaseko, Chiaki;
- Takeuchi, Masahiro;
- Kumagai, Kyoya;
- Komatsu, Tsunehiko;
- Tanaka, Hiroaki;
- Hara, Satoru;
- Koizumi, Masayuki;
- Imai, Hidenori;
- Yokota, Akira;
- Takeuchi, Masami;
- Inokuchi, Koiti;
- Matsuura, Yasuhiro;
- Aotsuka, Nobuyuki;
- Wakita, Hisashi
Publication type:
Article
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR<sup>4.5</sup>): The phase 2, multicenter N‐Road study.
Published in:
Cancer Medicine, 2020, v. 9, n. 11, p. 3742, doi. 10.1002/cam4.3034
By:
- Nishiwaki, Kaichi;
- Sugimoto, Kei‐ji;
- Tamaki, Shigehisa;
- Hisatake, Junichi;
- Yokoyama, Hisayuki;
- Igarashi, Tadahiko;
- Shinagawa, Atsushi;
- Sugawara, Takeaki;
- Hara, Satoru;
- Fujikawa, Kazuhisa;
- Shimizu, Seiichi;
- Yujiri, Toshiaki;
- Tojo, Arinobu;
- Wakita, Hisashi
Publication type:
Article
Successful control of Epstein–Barr virus (EBV)‐infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Published in:
American Journal of Hematology, 2004, v. 76, n. 4, p. 368, doi. 10.1002/ajh.20121
By:
- Taeko Uehara;
- Chiaki Nakaseko;
- Satoru Hara;
- Akane Harima;
- Megumi Ejiri;
- Akira Yokota;
- Yasushi Saito;
- Miki Nishimura
Publication type:
Article
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
Published in:
NPJ Systems Biology & Applications, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41540-022-00248-3
By:
- Okamoto, Yuji;
- Hirano, Mitsuhito;
- Morino, Kai;
- Kajita, Masashi K.;
- Nakaoka, Shinji;
- Tsuda, Mayuko;
- Sugimoto, Kei-ji;
- Tamaki, Shigehisa;
- Hisatake, Junichi;
- Yokoyama, Hisayuki;
- Igarashi, Tadahiko;
- Shinagawa, Atsushi;
- Sugawara, Takeaki;
- Hara, Satoru;
- Fujikawa, Kazuhisa;
- Shimizu, Seiichi;
- Yujiri, Toshiaki;
- Wakita, Hisashi;
- Nishiwaki, Kaichi;
- Tojo, Arinobu
Publication type:
Article
In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection.
Published in:
European Journal of Immunology, 2005, v. 35, n. 2, p. 399, doi. 10.1002/eji.200324746
By:
- Takahashi, Shigekazu;
- Kataoka, Hiroshi;
- Hara, Satoru;
- Yokosuka, Tadashi;
- Takase, Kan;
- Yamasaki, Sho;
- Kobayashi, Wakana;
- Saito, Yasushi;
- Saito, Takashi
Publication type:
Article

Found: 7

Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein–Barr virus infection.

CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.

Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR<sup>4.5</sup>): The phase 2, multicenter N‐Road study.

Successful control of Epstein–Barr virus (EBV)‐infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.

Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.

In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection.